Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skin Reaction to Cetuximab for Treatment Selection in Head and Neck Cancer
NCT01472653Phase 2Unknown
- Sponsor
- Institute of Oncology Ljubljana
- Start
- Dec 2011
- Primary completion
- Mar 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Institute of Oncology Ljubljana. Status: unknown.
02
Drugs
cetuximab
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01472653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01472653.